Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Galera Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Galera Therapeutics Inc market cap is $1.44M.
What is the 52-week high for Galera Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Galera Therapeutics Inc 52 week high is $0.08 as of October 07, 2025.
What is the 52-week low for Galera Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Galera Therapeutics Inc 52 week low is $0.0153 as of October 07, 2025.
What is Galera Therapeutics Inc stock price today?
Galera Therapeutics Inc stock price today is $0.018.
What was Galera Therapeutics Inc stock price yesterday?
Galera Therapeutics Inc stock price yesterday was $0.019.
What is the PE ratio of Galera Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Galera Therapeutics Inc’s P/E ratio is -0.09.
What is the Price-to-Book ratio of Galera Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Galera Therapeutics Inc P/B ratio is -0.0099.
What is the 50-day moving average of Galera Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Galera Therapeutics Inc 50-day moving average is $0.0208.
How many employess does Galera Therapeutics Inc has?